Author | Justin F. Gainor, MD | OncLive

Author | Justin F. Gainor, MD

Articles

Dr. Gainor on Neoadjuvant Use of Biomarkers in Nonmetastatic Lung Cancer

January 30, 2020

Video

Justin F. Gainor, MD, discusses a neoadjuvant use of biomarkers in nonmetastatic lung cancer.

Dr. Gainor on Neoadjuvant Checkpoint Blockade in NSCLC

September 13, 2019

Video

Justin F. Gainor, MD, director of Targeted Immunotherapy, Massachusetts General Hospital, and assistant professor of medicine, Harvard Medical School, discusses neoadjuvant checkpoint blockade in non–small cell lung cancer (NSCLC).

Dr. Gainor on Subgroup Analyses From the PACIFIC Trial in NSCLC

July 17, 2019

Video

Justin F. Gainor, MD, director of Targeted Immunotherapy, Massachusetts General Hospital, and assistant professor of medicine, Harvard Medical School, discusses subgroup analyses from the phase III PACIFIC trial in unresectable stage III non–small cell lung cancer (NSCLC).

Dr. Gainor on the PACIFIC-2 Trial in Stage III NSCLC

June 25, 2019

Video

Justin F. Gainor, MD, director of Targeted Immunotherapy, Massachusetts General Hospital, assistant professor of medicine, Harvard Medical School, discusses the phase III PACIFIC-2 trial in stage III non–small cell lung cancer (NSCLC).

x